topotecan has been researched along with nigericin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alnajim, J; Anantha, M; Bally, MB; Ramsay, E; Taggar, AS; Thomas, A; Webb, M | 1 |
| Cui, J; Li, C; Li, Y; Wang, C; Wei, N; Xiu, X; Zhang, L | 1 |
2 other study(ies) available for topotecan and nigericin
| Article | Year |
|---|---|
Copper-topotecan complexation mediates drug accumulation into liposomes.
Topics: Buffers; Calcimycin; Cations, Divalent; Chemical Precipitation; Cholesterol; Copper; Cryoelectron Microscopy; Doxorubicin; Drug Compounding; Hydrogen-Ion Concentration; Lactones; Liposomes; Manganese Compounds; Molecular Structure; Nigericin; Phosphatidylcholines; Proton-Motive Force; Sulfates; Topotecan | 2006 |
Nigericin-mediated liposome loading of topotecan: is nigericin a potential drug release regulator?
Topics: Animals; Cell Line, Tumor; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Nigericin; Survival Analysis; Time Factors; Topoisomerase I Inhibitors; Topotecan; Unilamellar Liposomes | 2010 |